Oxygenta Pharmaceutical Ltd - Board Meeting Outcome for Submission Of Un-Audited Financial Results For The Quarter Ended 30Th June, 2022
Ref: Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Download 
|
< Back |
| 12 Aug 2022 | |
| The Board at its meeting held today, i.e. Friday, 12th August, 2022, transacted inter-alia, the following businesses: 1. Financial Results: The Board approved the Un-audited Financial Results for the first quarter ended 30th June, 2022. In this regard please find the enclosed: ? Un-audited Financial Results of the Company for the quarter ended 30th June, 2022 ? Limited Review Report in respect of the Un-audited Financial Results of the Company for the first quarter ended 30th June, 2022 2. Other Corporate matters This is for your information and records. | |
| View all announcements for Oxygenta Pharmaceutical Ltd | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback